Endoglin was identified as a cell-surface glycoprotein in an acute lymphoblastic leukaemia cell line [6], and later it was demonstrated to be an accessory receptor for transforming growth factor-β (TGF-β) [7,8]. This evidence concerns the gene ENG and acute lymphoblastic leukemia.